Bilateral papillitis associated with Cafergot therapy.
D000328:Adult; D002110:Caffeine / Q000009:adverse effects / Q000627:therapeutic use; D004878:Ergotamine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D009902:Optic Neuritis / Q000139:chemically induced*; D010210:Papillary Muscles / Q000187:drug effects*; D010211:Papilledema / Q000139:chemically induced; D012607:Scotoma / Q000139:chemically induced; D014792:Visual Acuity; D014794:Visual Fields
D002110:Caffeine; D004878:Ergotamine